INVITRO PARAMETERS WHICH MAY PREDICT CLINICAL-RESPONSE OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TO DEOXYCOFORMYCIN (DCF)

被引：0
|
作者：
YU, AL [1 ]
QIAO, CN [1 ]
DILLMAN, RO [1 ]
MATSUMOTO, SS [1 ]
机构：
[1] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [31] INVITRO IMMUNOLOGICAL STUDIES IN PATIENTS SUFFERING FROM CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND FREQUENT INFECTIONS
    GLUCK, S
    KOSTER, W
    SPALL, I
    SCHNEIDER, W
    BLUT, 1987, 55 (04): : 299 - 299
  • [32] AUTOLOGOUS MIXED LYMPHOCYTE-REACTION (AMLR) IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) IN CLINICAL REMISSION
    REUBEN, J
    QUESADA, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 319 - 319
  • [33] INTERFERON-ALPHA-2 IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL-RESPONSE, SERUM CYTOKINE LEVELS, AND IMMUNOPHENOTYPE MODULATION
    MORABITO, F
    CALLEA, V
    OLIVA, B
    STELITANO, C
    VINCELLI, I
    MOLICA, S
    ALBERTI, A
    BRUGIATELLI, M
    NOBILE, F
    LEUKEMIA, 1993, 7 (03) : 366 - 371
  • [34] Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab
    Byrd, JC
    Smith, L
    Hackbarth, ML
    Flinn, IW
    Young, D
    Proffitt, JH
    Heerema, NA
    CANCER RESEARCH, 2003, 63 (01) : 36 - 38
  • [35] CLINICAL-RESPONSE TO BUSRAMUSTINE (KM-2210) IN CHRONIC LYMPHOCYTIC-LEUKEMIA - A PILOT EVALUATION OF ESTROGEN-RECEPTOR IN RELATION TO ITS THERAPEUTIC EFFECT
    NISHIKAWA, M
    UEMURA, Y
    KOMADA, F
    OHNO, T
    KATAYAMA, N
    SHIRAKAWA, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1988, 18 (04) : 327 - 333
  • [36] CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND IMMUNOCYTOMA (LP-IC) - CLINICAL AND PROGNOSTIC RELEVANCE OF THIS DISTINCTION
    ENGELHARD, M
    BRITTINGER, G
    HEINZ, R
    THEML, H
    BARTELS, H
    BINDER, T
    FULLE, HH
    GERHARTZ, H
    GUNZER, U
    LUDWIG, F
    LUDWIG, WD
    NOWICKI, L
    OERTEL, J
    PEES, HW
    PRALLE, H
    RUHL, U
    SCHILLING, CV
    SPANN, W
    SZEIMIES, U
    WETZEL, HJ
    ZWINGERS, T
    FELLER, AC
    STEIN, H
    LENNERT, K
    LEUKEMIA & LYMPHOMA, 1991, 5 : 161 - 173
  • [37] ENHANCED CYTO-TOXICITY AND INHIBITION OF REPAIR OF DNA SINGLE-STRAND BREAKS (SSB) IN IRRADIATED MURINE L5178Y LYMPHOBLASTS AND HUMAN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS TREATED WITH 2'-DEOXYCOFORMYCIN (DCF) AND DEOXYADENOSINE (DADO) INVITRO
    JOHNSTON, JB
    PUGH, L
    ISRAELS, LG
    BEGLEITER, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 3 - 3
  • [38] PREVIOUS CHEMOTHERAPY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) INDUCES RESISTANCE TO ALKYLATING-AGENTS, ANTHRACYCLINES AND ANTIMETABOLITES BUT SENSITIVITY TO METHYLPREDNISOLONE INVITRO
    BOSANQUET, AG
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 41 - 41
  • [39] A patient with chronic lymphocytic leukemia and acquired angioedema: correlation of clinical and biochemical response to CLL therapy
    Mohyuddin, G. R.
    Rabinowitz, I.
    ECANCERMEDICALSCIENCE, 2013, 7
  • [40] Clinical and biological predictivity of LH750 lymphocyte positional parameters in chronic lymphocytic leukemia (CLL)
    Garzia, M.
    Laurenti, L.
    Tarnani, M.
    De, Padua L.
    Chiusolo, F.
    Di, Mario A.
    Rumi, C.
    Zini, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 42 - 42
12345